SÚKL grants consent to begin DUOFAG phase II B

The Czech medicines regulator SÚKL has granted consent to begin phase II B clinical evaluation of DUOFAG®. This follows completed phase I, which confirmed the product’s safety, and ongoing phase II A examining efficacy in patients with complicated bacterial infections.